Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of MEDINET Co., Ltd.. A complete text table follows the diagram.
Contract cell manufacturing supplies current revenue as the company expands CDMO and regenerative-product development.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Contract Cell Manufacturing Business | 1 | 414M | 99.9% of reported total |
| Cellular & tissue-based product business | 1 | 0.3 | 0.1% of reported total |
| Revenues From External Customers | 2 | 414M | Reported six-month total · ¥414M |
| Operating loss | 2 | 630M | Absolute value of reported operating loss |
| Operating costs & expenses | 3 | 1.0B | Revenue plus reported operating loss |
| From | To | Value |
|---|---|---|
| Contract Cell Manufacturing Business | Revenues From External Customers | 414M |
| Cellular & tissue-based product business | Revenues From External Customers | 0.3 |
| Revenues From External Customers | Operating costs & expenses | 414M |
| Operating loss | Operating costs & expenses | 630M |